Detalles de la búsqueda
1.
Sulopenem for the Treatment of Complicated Urinary Tract Infections Including Pyelonephritis: A Phase 3, Randomized Trial.
Clin Infect Dis
; 76(1): 78-88, 2023 01 06.
Artículo
Inglés
| MEDLINE | ID: mdl-36068705
2.
Sulopenem or Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infections in Women: A Phase 3, Randomized Trial.
Clin Infect Dis
; 76(1): 66-77, 2023 01 06.
Artículo
Inglés
| MEDLINE | ID: mdl-36069202
3.
Applying Desirability of Outcome Ranking End Point to Randomized Trial of Sulopenem for the Treatment of Complicated Urinary Tract Infections.
Clin Infect Dis
; 76(12): 2213-2215, 2023 06 16.
Artículo
Inglés
| MEDLINE | ID: mdl-36949581
4.
Applying Desirability of Outcome Ranking End Points.
Clin Infect Dis
; 77(1): 159-161, 2023 07 05.
Artículo
Inglés
| MEDLINE | ID: mdl-36974506
5.
Outcomes in Patients with Staphylococcus aureus Bacteremia Treated with Dalbavancin in Clinical Trials.
Infect Dis Ther
; 11(1): 423-434, 2022 Feb.
Artículo
Inglés
| MEDLINE | ID: mdl-34905144
6.
Safety of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Nephrotoxicity Rates Compared with Vancomycin: A Post Hoc Analysis of Three Clinical Trials.
Infect Dis Ther
; 10(1): 471-481, 2021 Mar.
Artículo
Inglés
| MEDLINE | ID: mdl-33515414
7.
Necrotizing Fasciitis Within 72 hours After Presentation with Skin and Skin Structure Infection.
West J Emerg Med
; 21(4): 943-948, 2020 Jul 10.
Artículo
Inglés
| MEDLINE | ID: mdl-32726268
8.
Single-dose dalbavancin and patient satisfaction in an outpatient setting in the treatment of acute bacterial skin and skin structure infections.
J Glob Antimicrob Resist
; 17: 60-65, 2019 06.
Artículo
Inglés
| MEDLINE | ID: mdl-30797084
9.
Treatment of acute bacterial skin and skin structure infection with single-dose dalbavancin in persons who inject drugs.
Drugs Context
; 7: 212559, 2018.
Artículo
Inglés
| MEDLINE | ID: mdl-30574170
Resultados
1 -
9
de 9
1
Próxima >
>>